Publications of the group

Modified

October 9, 2026

Here we list the publications that the group has written or contributed to.

Accepted or published

2026

Roberts, K., Palmer, J., Volpe, J., Zhong, W. and McIntosh, A., 2026. Quantitative Dose Optimization for Gene Therapy Trials: Implications for Project Optimus and Early-Phase Design. Pharmaceutical Statistics, 25(5). doi

Anderson, P., Ananthakrishnan, R., Xu, Z., Rantell, K.R., Bell, S., Li, D., Xue, A. and Chiang, A.Y., 2026. Statistical analysis plan considerations for autologous cell and cell-based gene therapy clinical trials. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Ananthakrishnan, R., Adiwijaya, B., Chiang, A.Y., Han, C., He, Q.A., Lewandowski, A., Liu, R., Shen, F., Sun, H. and Li, D., 2026. Overview of dose- finding designs and trials in cell and gene therapies. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Anderson, P., Xu, Z., Degtyarev, E., Ananthakrishnan, R., Ballarini, N., He, A., Zhang, W. and Li, D., 2026. Pivotal trial design considerations for new and next generation cell and gene therapies. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Choi, S. and Dave, K., 2026. A systematic analysis of the inherent dose uncertainty in autologous CAR T-cell products. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Kang, R., Yamaguchi, Y. and Han, C., 2026. Bayesian quantitative decision- making framework in cell and gene therapy development for rare diseases. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Kim, Y., Wen, S., Rantell, K.R., Xu, Z. and Anderson, P., 2026. Real-world data and evidence in the development of cell and gene therapies. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Speth, K., Sengupta, S., Shamsuzzaman, M., Whitmore, J., Li, D., Chiang, A.Y., Xu, Z. and Song, Q., 2026. Advancing cell and gene therapy: Application of AI/ML in clinical development and patient management. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Choi, S., Chiang, A.Y., Cheng, C., Dai, T., Yeh, T.M. and Pikounis, B., 2026. Applications of correlative analysis for chemistry, manufacturing and controls in cell and gene therapy. Journal of Biopharmaceutical Statistics. Advance online publication. doi

2025

Wen, S., Anderson, P., Duan, R., Sverdlov, O. and Chiang, A.Y., 2025. Estimands for long-term follow-up trials in gene therapy products. Journal of Biopharmaceutical Statistics. Advance online publication. doi

Yi, S., Wu, C., McIntosh, A., Santaella, M.E., Robinson, T.M. and Liao, M.Z., 2025. Cell and Gene Therapy: Transforming Treatment Paradigms for Patient- Centric Care. Clinical and Translational Science, 18(12). doi

2024

Li, D., Xu, Z., Wen, S., Ananthakrishnan, R., Kim, Y., Rantell, K.R., Anderson, P., Whitmore, J. and Chiang, A., 2024. Challenges and Lessons Learned in Autologous Chimeric Antigen Receptor T-Cell Therapy Development from a Statistical Perspective. Therapeutic Innovation & Regulatory Science, 58(5), pp.817–830. doi

McIntosh, A. and Sverdlov, O. eds., 2024. Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations. Chapman and Hall/CRC. doi

Submitted

Nothing under review at present.